Faculty Disclosures
| Joseph C. Griffis, PhD |
Dr. Griffis has nothing to disclose. |
| Jason Carmel, MD, PhD |
Dr. Carmel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BackStop Neural. Dr. Carmel has stock in BackStop Neural. Dr. Carmel has stock in SharperSense. Dr. Carmel has received intellectual property interests from a discovery or technology relating to health care. |
| Marjorie Soltis, MD |
Dr. Soltis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. |
| Asmaa Mhanna, MD |
Dr. Mhanna has nothing to disclose. |
| Bahadir M. Samur, MD |
Dr. Samur has nothing to disclose. |
| Michelle R. Christie, MD |
Dr. Christie has nothing to disclose. |
| Aaron D. Boes, MD |
Dr. Boes has stock in NeuroPred, Inc. The institution of Dr. Boes has received research support from NIH. |
| Ameera Sheikh, MD |
Dr. Sheikh has nothing to disclose. |
| Scott Dixon, PhD |
Dr. Dixon has nothing to disclose. |
| Hyunglok Chung, PhD |
Dr. Chung has nothing to disclose. |
| Sneha Sadhu |
Ms. Sadhu has nothing to disclose. |
| Nicolas J. Abreu, MD |
Dr. Abreu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo. The institution of Dr. Abreu has received research support from BDSRA Foundation. |
| Michelle Corkrum, MD, PhD |
Dr. Corkrum has nothing to disclose. |
| Nathaniel Denton |
Mr. Denton has nothing to disclose. |
| Andre Lapeyre Rivera |
Mr. Lapeyre Rivera has nothing to disclose. |
| Kristopher Kahle |
No disclosure on file
|
| Keith Van Haren, MD |
Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. |
| David E. Horvat, MD |
Dr. Horvat has nothing to disclose. |
| Michelle Machie, MD |
Dr. Machie has nothing to disclose. |
| Isha Srivastava, MD, PhD |
Dr. Srivastava has nothing to disclose. |
| Garrett Allington |
Mr. Allington has nothing to disclose. |
| Sharvari V. Mandge |
Ms. Mandge has nothing to disclose. |
| Kedous Y. Mekbib, MD |
Dr. Mekbib has nothing to disclose. |
| Renjie Li |
Mr. Li has received personal compensation for serving as an employee of Ambit. |
| Heath Yancey |
Mr. Yancey has nothing to disclose. |
| Hyunyong Koh, MD, PhD |
Dr. Koh has nothing to disclose. |
| Alice Barry |
Miss Barry has nothing to disclose. |
| Joel Bruss, BA |
Mr. Bruss has stock in NeuroPred. Mr. Bruss has received intellectual property interests from a discovery or technology relating to health care. |
| Evan Dennis |
Mr. Dennis has nothing to disclose. |
| Claudia Cruzalegui Bazán |
Miss Cruzalegui Bazán has nothing to disclose. |
| Christine Fox, MD |
The institution of Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Competitive Drug Development International. The institution of Dr. Fox has received research support from American Heart Association/Bugher Foundation. The institution of Dr. Fox has received research support from NIN/NINDS. The institution of Dr. Fox has received research support from American Heart Association/Bugher Foundation. Dr. Fox has received publishing royalties from a publication relating to health care. |